{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 413883923
| IUPAC_name = (''RS'')-1-<nowiki/>{7-[2-hydroxy-3-(propan-2-ylamino)propoxy]- 1-benzofuran-2-yl}ethanone
| image = Befunolol.svg

<!--Clinical data-->
| tradename =  Benfuran, Bentos, Betaclar, Glauconex   
| Drugs.com = {{drugs.com|international|befunolol}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 39552-01-7
| ATC_prefix = S01
| ATC_suffix = ED06
| PubChem = 2309
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB09013
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2219
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 418546MT3A
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07496
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 153984

<!--Chemical data-->
| C=16 | H=21 | N=1 | O=4
| molecular_weight = 291.342 g/mol
| smiles = O=C(c2oc1c(OCC(O)CNC(C)C)cccc1c2)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H21NO4/c1-10(2)17-8-13(19)9-20-14-6-4-5-12-7-15(11(3)18)21-16(12)14/h4-7,10,13,17,19H,8-9H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ZPQPDBIHYCBNIG-UHFFFAOYSA-N
}}

'''Befunolol''' ([[International Nonproprietary Name|INN]]) is a [[beta blocker]] with [[beta blocker#Intrinsic sympathomimetic activity|intrinsic sympathomimetic activity]] used in the management of [[glaucoma|open-angle glaucoma]].<ref>{{cite journal|author=Stephan Reichl, Christel C Müller-Goymann|title=The use of a porcine organotypic cornea construct for permeation studies from formulations containing befunolol hydrochloride |journal=International Journal of Pharmaceutics |volume=250 |issue = 1 |date = 2 January 2003 |pages = 191–201 |url = http://www.sciencedirect.com/science/article/pii/S0378517302005410 |doi=10.1016/S0378-5173(02)00541-0}}</ref> It also acts as a [[Beta-adrenergic agonist|β adrenoreceptor]] [[partial agonist]].<ref>{{cite journal|last1=Koike|first1=K|last2=Takayanagi|first2=I|title=A beta-adrenergic partial agonist (befunolol) discriminates two different affinity sites|journal=Japanese Journal of Pharmacology|date=October 1986|volume=42|issue=2|pages=325–8|pmid=2879061|doi=10.1254/jjp.42.325}}<!--|accessdate=6 March 2016--></ref><ref>{{cite journal|last1=Takayanagi|first1=I|last2=Koike|first2=K|title=A beta-adrenoceptor blocking agent, befunolol as a partial agonist in isolated organs|journal=General Pharmacology: The Vascular System|date=January 1985|volume=16|issue=3|pages=265–267|doi=10.1016/0306-3623(85)90080-1}}<!--|accessdate=6 March 2016--></ref> Befunolol was introduced in Japan in 1983 by Kakenyaku Kako Co. under the trade name Bentos.<ref>{{cite book|title=Pharmaceutical Manufacturing Encyclopedia|date=January 14, 2008|publisher=William Andrew Publishing|location=Norwich, N.Y.|isbn=978-0815515265|page=542|edition=3rd revised}}</ref>

== References ==
{{Reflist}}

{{Adrenergic agonists}}
{{Antiglaucoma preparations and miotics}}

[[Category:Alcohols]]
[[Category:Amines]]
[[Category:Benzofurans]]
[[Category:Beta blockers]]
[[Category:Ketones]]
[[Category:Phenol ethers]]


{{antihypertensive-stub}}